je.st
news
ABL Successfully Completes Drug Product Manufacture Of Ebola Vaccine For Clinical Trial
2015-07-01 08:22:45| drugdiscoveryonline Home Page
ABL, Inc. (ABL), a contract research and manufacturing organization to the biopharmaceutical industry, is pleased to announce the successful aseptic formulation and fill of an Ebola vaccine candidate for Emergent BioSolutions Inc. (EMERGENT)
Tags: product
trial
drug
successfully
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||